Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Antigen-bound and free β-amyloid autoantibodies in serum of healthy adults.

Maftei M, Thurm F, Leirer VM, von Arnim CA, Elbert T, Przybylski M, Kolassa IT, Manea M.

PLoS One. 2012;7(9):e44516. doi: 10.1371/journal.pone.0044516. Epub 2012 Sep 4. Erratum in: PLoS One. 2012;7(11):doi/10.1371/annotation/93ade307-e8d8-40f5-ad57-9e323548838b.

2.

Increased levels of antigen-bound β-amyloid autoantibodies in serum and cerebrospinal fluid of Alzheimer's disease patients.

Maftei M, Thurm F, Schnack C, Tumani H, Otto M, Elbert T, Kolassa IT, Przybylski M, Manea M, von Arnim CA.

PLoS One. 2013 Jul 18;8(7):e68996. doi: 10.1371/journal.pone.0068996. Print 2013.

3.

Increased Number of Plasma B Cells Producing Autoantibodies Against Aβ42 Protofibrils in Alzheimer's Disease.

Söllvander S, Ekholm-Pettersson F, Brundin RM, Westman G, Kilander L, Paulie S, Lannfelt L, Sehlin D.

J Alzheimers Dis. 2015;48(1):63-72. doi: 10.3233/JAD-150236.

4.

Circulating immune complexes of Abeta and IgM in plasma of patients with Alzheimer's disease.

Marcello A, Wirths O, Schneider-Axmann T, Degerman-Gunnarsson M, Lannfelt L, Bayer TA.

J Neural Transm (Vienna). 2009 Jul;116(7):913-20. doi: 10.1007/s00702-009-0224-y. Epub 2009 May 5.

5.

Cognitive consequences of high Aβ amyloid in mild cognitive impairment and healthy older adults: implications for early detection of Alzheimer's disease.

Lim YY, Ellis KA, Harrington K, Kamer A, Pietrzak RH, Bush AI, Darby D, Martins RN, Masters CL, Rowe CC, Savage G, Szoeke C, Villemagne VL, Ames D, Maruff P.

Neuropsychology. 2013 May;27(3):322-32. doi: 10.1037/a0032321.

PMID:
23688214
6.

Dissociated amyloid-beta antibody levels as a serum biomarker for the progression of Alzheimer's disease: a population-based study.

Gustaw-Rothenberg KA, Siedlak SL, Bonda DJ, Lerner A, Tabaton M, Perry G, Smith MA.

Exp Gerontol. 2010 Jan;45(1):47-52. doi: 10.1016/j.exger.2009.10.003. Epub 2009 Oct 9.

7.
8.

Autoantibodies against amyloid and glial-derived antigens are increased in serum and cerebrospinal fluid of Lewy body-associated dementias.

Maetzler W, Berg D, Synofzik M, Brockmann K, Godau J, Melms A, Gasser T, Hörnig S, Langkamp M.

J Alzheimers Dis. 2011;26(1):171-9. doi: 10.3233/JAD-2011-110221.

PMID:
21593566
9.

Autoimmune responses to amyloid structures of Abeta(25-35) peptide and human lysozyme in the serum of patients with progressive Alzheimer's disease.

Gruden MA, Davudova TB, Malisauskas M, Zamotin VV, Sewell RD, Voskresenskaya NI, Kostanyan IA, Sherstnev VV, Morozova-Roche LA.

Dement Geriatr Cogn Disord. 2004;18(2):165-71. Epub 2004 Jun 21.

PMID:
15211072
10.

A sensitive aβ oligomer assay discriminates Alzheimer's and aged control cerebrospinal fluid.

Savage MJ, Kalinina J, Wolfe A, Tugusheva K, Korn R, Cash-Mason T, Maxwell JW, Hatcher NG, Haugabook SJ, Wu G, Howell BJ, Renger JJ, Shughrue PJ, McCampbell A.

J Neurosci. 2014 Feb 19;34(8):2884-97. doi: 10.1523/JNEUROSCI.1675-13.2014.

11.

Reduced levels of IgM autoantibodies against N-truncated pyroglutamate Aβ in plasma of patients with Alzheimer's disease.

Marcello A, Wirths O, Schneider-Axmann T, Degerman-Gunnarsson M, Lannfelt L, Bayer TA.

Neurobiol Aging. 2011 Aug;32(8):1379-87. doi: 10.1016/j.neurobiolaging.2009.08.011. Epub 2009 Sep 24.

PMID:
19781815
12.

Interactions between amyloid-β and tau in cerebrospinal fluid of people with mild cognitive impairment and Alzheimer's disease.

Kristofikova Z, Ricny J, Kolarova M, Vyhnalek M, Hort J, Laczo J, Sirova J, Ripova D.

J Alzheimers Dis. 2014;42 Suppl 3:S91-8. doi: 10.3233/JAD-132393.

PMID:
24670397
13.

Correlation of Aβ oligomer levels in matched cerebrospinal fluid and serum samples.

Kasai T, Tokuda T, Taylor M, Kondo M, Mann DM, Foulds PG, Nakagawa M, Allsop D.

Neurosci Lett. 2013 Sep 13;551:17-22. doi: 10.1016/j.neulet.2013.06.029. Epub 2013 Jun 27.

PMID:
23811027
14.

Amyloid-β 42/40 cerebrospinal fluid concentration ratio in the diagnostics of Alzheimer's disease: validation of two novel assays.

Lewczuk P, Lelental N, Spitzer P, Maler JM, Kornhuber J.

J Alzheimers Dis. 2015;43(1):183-91. doi: 10.3233/JAD-140771.

PMID:
25079805
15.

Beta-amyloid auto-antibodies are reduced in Alzheimer's disease.

Qu BX, Gong Y, Moore C, Fu M, German DC, Chang LY, Rosenberg R, Diaz-Arrastia R.

J Neuroimmunol. 2014 Sep 15;274(1-2):168-73. doi: 10.1016/j.jneuroim.2014.06.017. Epub 2014 Jun 27.

16.

Naturally occurring autoantibodies against beta-amyloid: investigating their role in transgenic animal and in vitro models of Alzheimer's disease.

Dodel R, Balakrishnan K, Keyvani K, Deuster O, Neff F, Andrei-Selmer LC, Röskam S, Stüer C, Al-Abed Y, Noelker C, Balzer-Geldsetzer M, Oertel W, Du Y, Bacher M.

J Neurosci. 2011 Apr 13;31(15):5847-54. doi: 10.1523/JNEUROSCI.4401-10.2011.

17.

Plasma amyloid-β oligomers and soluble tumor necrosis factor receptors as potential biomarkers of AD.

Zhang J, Peng M, Jia J.

Curr Alzheimer Res. 2014 May;11(4):325-31.

PMID:
24635842
18.

Serum insulin-like growth factor-I and amyloid beta protein in Alzheimer's disease: relationship with cognitive function.

Kimoto A, Kasanuki K, Kumagai R, Shibata N, Ichimiya Y, Arai H.

Psychogeriatrics. 2016 Jul;16(4):247-54. doi: 10.1111/psyg.12149. Epub 2015 Oct 6.

PMID:
26439951
19.

Accuracy of brain amyloid detection in clinical practice using cerebrospinal fluid β-amyloid 42: a cross-validation study against amyloid positron emission tomography.

Palmqvist S, Zetterberg H, Blennow K, Vestberg S, Andreasson U, Brooks DJ, Owenius R, Hägerström D, Wollmer P, Minthon L, Hansson O.

JAMA Neurol. 2014 Oct;71(10):1282-9. doi: 10.1001/jamaneurol.2014.1358.

PMID:
25155658
20.

The relationship of plasma Aβ levels to dementia in aging individuals with mild cognitive impairment.

Fei M, Jianghua W, Rujuan M, Wei Z, Qian W.

J Neurol Sci. 2011 Jun 15;305(1-2):92-6. doi: 10.1016/j.jns.2011.03.005. Epub 2011 Mar 26.

PMID:
21440911

Supplemental Content

Support Center